Chembio Diagnostics (NSDQ:CEMI) announced that it received a $12.7 million contract from BARDA for its rapid COVID-19 test. Hauppauge, N.Y.-based Chembio said in a news release that the contract will support the development of and pursuit of FDA emergency use authorization (EUA) for its rapid, multi-plex DPP respiratory antigen panel point-of-care testing system ahead of […]
Contract Manufacturing
Steris closes on Key Surgical buy
Steris (NYSE:STE) announced this week that it has closed on its $850 million purchase of Key Surgical, a manufacturer of disposable hospital and surgical products. Mentor, Ohio-based Steris now anticipates that Key Surgical will add about 35% more revenue and adjusted earnings per diluted share in the fiscal year than initially anticipated with a December 31, […]
MedTech 100 roundup: Stocks remain high after record-setting week
Medtech stocks have been on the rise since positive news regarding COVID-19 vaccines broke last week, breaking a record in the process. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 98.99 (Nov. 13), marking a 1.4% uptick from the 97.62 points registered at the […]
Vibalogics to invest $150M in Boston virotherapy facility
Vibalogics announced that it initiated the first phase of its planned $150 million investment in a virotherapy facility near Boston. The global contract development and manufacturing organization (CDMO) has a three-year investment plan which includes building a 110,000 square-foot facility, with the $150 million covering redevelopment, equipment and personnel, according to a news release. Vibalogics […]
Baxter lands major DoD contract
The U.S. Defense Dept. (DoD) announced that it awarded Baxter (NYSE:BAX) $40 million for its infusion pumps and accessories. Baxter’s contract includes a maximum $40 million fixed-price award with economic-price-adjustment and indefinite-delivery/indefinite-quantity for its infusion pumps and accessories. The competitive acquisition had 105 offers received. Get the full story at our sister site, Drug Delivery Business […]
Sotera Health files for $1.1 billion IPO
Sotera Health has filed with the SEC to confirm its intent to raise nearly $1.1 billion in an initial public offering. Broadview Heights, Ohio-based Sotera Health said in the filing out yesterday that it expects to sell 46.6 million shares of its common stock at an assumed IPO price of $21.50 per share, totaling $949.3 […]
Canada to buy 7.6M BD rapid COVID-19 tests
Becton Dickinson (NYSE:BDX) announced that Health Canada authorized its rapid COVID-19 tests and will buy 7.6 million of them. Under interim order, Health Canada authorized BD’s rapid, point-of-care SARS-CoV-2 antigen test for use with the BD Veritor Plus system. The order for 7.6 million tests runs through March 2021 in an effort to support Canada’s planning […]
3M lands $37.5M federal mask contract
The U.S. Department of Defense announced that it issued nearly $37.5 million to 3M (NYSE:MMM) for expanded production of N95 respirators. St. Paul, Minn.-based 3M will receive approximately $37.46 million in a firm-fixed-price modification to expand the production capacity for its N95 respirators, which have been in high demand since the beginning of the COVID-19 pandemic. […]
Joe Biden’s plan for COVID-19 and how the industry is reacting
Following the weekend’s news that Joe Biden is now president-elect of the U.S., plenty of focus is shifting to his plan for COVID-19. While positive news regarding Pfizer and BioNTech’s vaccine candidate came through this morning, the pandemic is still roaring on, with the U.S. hitting a record 128,000 new cases on Saturday as the […]
Report: Some nursing homes refuse to use COVID-19 rapid antigen tests
Many rapid COVID-19 tests are going unused in nursing homes as there reportedly remain concerns over accuracy in detecting the virus. The Wall Street Journal reports that a federal survey of nursing homes found that 30% of 13,150 facilities that had rapid testing equipment for at least two weeks did not use it to test […]
Hologic receives $119M contract from U.S. Air Force for COVID-19 molecular tests
Hologic (NSDQ:HOLX) announced that it received a $119 million contract from the U.S. government to expand production of its COVID-19 tests. Under the contract, Hologic will increase the production capacity of its Panther Fusion SARS-CoV-2 assay and Aptima SARS-CoV-2 assay, both of which possess emergency use authorization, according to a news release. The tests run on […]
